BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1134 related articles for article (PubMed ID: 19752225)

  • 21. Inhibition of angiogenesis by the cancer chemopreventive agent conjugated linoleic acid.
    Masso-Welch PA; Zangani D; Ip C; Vaughan MM; Shoemaker S; Ramirez RA; Ip MM
    Cancer Res; 2002 Aug; 62(15):4383-9. PubMed ID: 12154044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (+)-Catechin inhibits tumour angiogenesis and regulates the production of nitric oxide and TNF-alpha in LPS-stimulated macrophages.
    Guruvayoorappan C; Kuttan G
    Innate Immun; 2008 Jun; 14(3):160-74. PubMed ID: 18562575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of macrophages in inflammatory lymphangiogenesis: Enhanced production of vascular endothelial growth factor C and D through NF-kappaB activation.
    Watari K; Nakao S; Fotovati A; Basaki Y; Hosoi F; Bereczky B; Higuchi R; Miyamoto T; Kuwano M; Ono M
    Biochem Biophys Res Commun; 2008 Dec; 377(3):826-31. PubMed ID: 18951870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vernolide-A inhibits tumour specific angiogenesis by regulating proinflammatory cytokines, VEGF, MMPs and TIMP.
    Pratheeshkumar P; Kuttan G
    Eur J Pharmacol; 2011 Apr; 656(1-3):10-8. PubMed ID: 21256125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VEGF and inhibitors of TGFbeta type-I receptor kinase synergistically promote blood-vessel formation by inducing alpha5-integrin expression.
    Liu Z; Kobayashi K; van Dinther M; van Heiningen SH; Valdimarsdottir G; van Laar T; Scharpfenecker M; Löwik CW; Goumans MJ; Ten Dijke P; Pardali E
    J Cell Sci; 2009 Sep; 122(Pt 18):3294-302. PubMed ID: 19706683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Essential role for platelet-activating factor-induced NF-kappaB activation in macrophage-derived angiogenesis.
    Seo KH; Ko HM; Choi JH; Jung HH; Chun YH; Choi IW; Lee HK; Im SY
    Eur J Immunol; 2004 Aug; 34(8):2129-37. PubMed ID: 15259010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiopoietin-1 and vascular endothelial growth factor induce expression of inflammatory cytokines before angiogenesis.
    Aplin AC; Gelati M; Fogel E; Carnevale E; Nicosia RF
    Physiol Genomics; 2006 Oct; 27(1):20-8. PubMed ID: 17018690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiangiogenic activity of Diallyl Sulfide (DAS).
    Thejass P; Kuttan G
    Int Immunopharmacol; 2007 Mar; 7(3):295-305. PubMed ID: 17276887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of the cellular sensor that stimulates the inflammatory response to sterile cell death.
    Kono H; Karmarkar D; Iwakura Y; Rock KL
    J Immunol; 2010 Apr; 184(8):4470-8. PubMed ID: 20220089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue-specific microvascular endothelial cell lines from H-2K(b)-tsA58 mice for studies of angiogenesis and metastasis.
    Langley RR; Ramirez KM; Tsan RZ; Van Arsdall M; Nilsson MB; Fidler IJ
    Cancer Res; 2003 Jun; 63(11):2971-6. PubMed ID: 12782605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of IFN-gamma production by TNF-alpha in macrophages from the tumor environment: significance as an angiogenic switch.
    Lee H; Baek S; Joe SJ; Pyo SN
    Int Immunopharmacol; 2006 Jan; 6(1):71-8. PubMed ID: 16332515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular endothelial growth factor receptor-1 signaling promotes mobilization of macrophage lineage cells from bone marrow and stimulates solid tumor growth.
    Muramatsu M; Yamamoto S; Osawa T; Shibuya M
    Cancer Res; 2010 Oct; 70(20):8211-21. PubMed ID: 20924106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.
    Scaldaferri F; Vetrano S; Sans M; Arena V; Straface G; Stigliano E; Repici A; Sturm A; Malesci A; Panes J; Yla-Herttuala S; Fiocchi C; Danese S
    Gastroenterology; 2009 Feb; 136(2):585-95.e5. PubMed ID: 19013462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 15(S)-hydroxyeicosatetraenoic acid-induced angiogenesis requires STAT3-dependent expression of VEGF.
    Srivastava K; Kundumani-Sridharan V; Zhang B; Bajpai AK; Rao GN
    Cancer Res; 2007 May; 67(9):4328-36. PubMed ID: 17483346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VEGFR1 tyrosine kinase signaling promotes lymphangiogenesis as well as angiogenesis indirectly via macrophage recruitment.
    Murakami M; Zheng Y; Hirashima M; Suda T; Morita Y; Ooehara J; Ema H; Fong GH; Shibuya M
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):658-64. PubMed ID: 18174461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The progression of inflammation parallels the dermal angiogenesis in a keratin 14 IL-4-transgenic model of atopic dermatitis.
    Chen L; Marble DJ; Agha R; Peterson JD; Becker RP; Jin T; Li J; Chan LS
    Microcirculation; 2008 Jan; 15(1):49-64. PubMed ID: 17952801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dexamethasone treatment and ICAM-1 deficiency impair VEGF-induced angiogenesis in adult brain.
    Kasselman LJ; Kintner J; Sideris A; Pasnikowski E; Krellman JW; Shah S; Rudge JS; Yancopoulos GD; Wiegand SJ; Croll SD
    J Vasc Res; 2007; 44(4):283-91. PubMed ID: 17406120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor.
    Passaniti A; Taylor RM; Pili R; Guo Y; Long PV; Haney JA; Pauly RR; Grant DS; Martin GR
    Lab Invest; 1992 Oct; 67(4):519-28. PubMed ID: 1279270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-1 is required for tumor invasiveness and angiogenesis.
    Voronov E; Shouval DS; Krelin Y; Cagnano E; Benharroch D; Iwakura Y; Dinarello CA; Apte RN
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2645-50. PubMed ID: 12598651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Piper longum inhibits VEGF and proinflammatory cytokines and tumor-induced angiogenesis in C57BL/6 mice.
    Sunila ES; Kuttan G
    Int Immunopharmacol; 2006 May; 6(5):733-41. PubMed ID: 16546703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.